See All Slides - tctmd.com

Slides

Presentation TCT 2012

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Two Distal Left Main Trifurcation Cases: My Solutions

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

Left Main Bifurcation Stenting: Highlights from the Last 12 Months

Presenter: David Kandzari

October 22, 2012

Presentation TCT 2012

The United Kingdom TAVR Registry

Presenter: Neil Moat

October 22, 2012

Presentation TCT 2012

REDUCE Trial Update

Presenter: John Rhodes

October 22, 2012

Presentation TCT 2012

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES

Presenter: Ted Feldman

October 22, 2012

Presentation TCT 2012

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

The Canadian TAVR Registry

Presenter: Josep Rodes-Cabau

October 22, 2012

Presentation TCT 2012

The Apica Left Ventricular Apical Access and Closure System: First-in-Human Use Experiences During TAVR

Presenter: Thomas Walther

October 22, 2012

Presentation TCT 2012

Gene Therapy for Peripheral Arterial Disease: Status Update

Presenter: Timothy Henry

October 22, 2012

Advertisement

Slides

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Two Distal Left Main Trifurcation Cases: My Solutions

Left Main Bifurcation Stenting: Highlights from the Last 12 Months

The United Kingdom TAVR Registry

REDUCE Trial Update

Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

The Canadian TAVR Registry

The Apica Left Ventricular Apical Access and Closure System: First-in-Human Use Experiences During TAVR

Gene Therapy for Peripheral Arterial Disease: Status Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content